Alamance Regional Medical Center

Burlington, North Carolina 27217

0 studies enrolling now · 13 studies all time

What they study most

Adenocarcinoma of the Colon, Adverse Event, Breast Cancer, Chronic Heart Failure, Colorectal Cancer, Congestive Heart Failure, Healthcare Associated Infections, Interdisciplinary Communication, Interpersonal Relations, Interprofessional Relations, Invasive Breast Cancer, Multidrug Resistant Organisms

Studies at this site

• Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer — Completed
• Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer — Completed
• Redesigning Systems to Improve Quality for Hospitalized Patients — Completed
• A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer — Completed
• A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer — Completed
• A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer — Status unconfirmed
• Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs) — Completed
• Educational Videos to Improve Patient Decision Making and Race Disparities in Implantable Cardioverter Defibrillator Use — Completed
• A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy — Completed
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
• Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg — Completed
• Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer — Completed
• EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed